Cargando…
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes and often induced by chemotherapy. Recombinant human interleukin-11 (rhIL-11) is a cytokine that can stimulate thrombopoiesis and is commonly used to treat thrombocytopenia. We observed the side effects of rhIL-11...
Autores principales: | Liu, Na-wei, Huang, Xin, Liu, Shuang, Liu, Wen-jian, Wang, Hua, Wang, Wei-da, Lu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803615/ https://www.ncbi.nlm.nih.gov/pubmed/30877597 http://dx.doi.org/10.1007/s00520-019-04734-z |
Ejemplares similares
-
A prospective interventional study of recombinant human interleukin-11 mouthwash in chemotherapy-induced oral mucositis
por: Wei, Hangping, et al.
Publicado: (2022) -
Platelet and peripheral white blood cell counts at diagnosis predict the response of adult immune thrombocytopenia to recombinant human interleukin-11: A retrospective, single-center, case–control study
por: Jin, Chenghao, et al.
Publicado: (2019) -
Efficacy of recombinant human interleukin-11 in preventing and treating oral mucositis after chemotherapy for patients with acute leukemia
por: Zhang, Yilin, et al.
Publicado: (2023) -
Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia
por: Kai-Feng, Wang, et al.
Publicado: (2011) -
The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia
por: Wang, Wenxian, et al.
Publicado: (2022)